Renewing US leadership: Policies to advance global health research
Tuesday, February 26, 2013
Kennedy Caucus Room (SR 325), Russell Senate Office Building
Lunch will be provided. Guests will have the opportunity to browse interactive displays from nonprofit groups to learn about the latest global health research.
The fruits of science have saved the lives of millions around the world. Investments in research from the US government have led to scientific breakthroughs in the development of vaccines, drugs, diagnostics, devices, insecticides, and other products for global public health. The world is now at a promising turning point, with many new tools on the cusp of development and delivery. However, at the same time that research is offering the possibility of new health tools that can make an impact worldwide, the economic environment in the United States is changing dramatically, putting global health research and other essential programs at risk. Join the Global Health Technologies Coalition (GHTC) for its fourth annual global health R&D briefing, where the coalition will launch its policy report with recommendations for the US government to strengthen its legacy in global health research. Speakers from a range of US federal agencies, research programs, and philanthropic groups will also discuss the considerable impact of US investments in science and innovation for global health. Lisa Cohen, executive director of the Washington Global Health Alliance, will be moderating the panel, which includes the following:
- Dr. Lee Hall, chief of the Parasitology and International Programs Branch, National Institute of Allergy and Infectious Diseases.
- Dr. Alan Magill, director of malaria, Bill & Melinda Gates Foundation.
- Dr. Caroline Ryan, deputy coordinator for technical leadership, The United States President’s Emergency Plan for AIDS Relief (PEPFAR).